Filter
|
|
|
|
|
|
GSE161676
|
MTX
|
|
|
GSM4912395
|
mll-af9 + kras g12d/+ (KF05)
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912480
|
MLL-AF9 baseline
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912481
|
Ptprca Disease mouse 1
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912482
|
PtprcaDisease mouse 2
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912483
|
NSG Disease mouse 4
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912484
|
NSG Disease mouse 6
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912485
|
MLL-AF9 baseline ATAC
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912548
|
mll-af9 (KF09)
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912549
|
mll-af9 + flt3 itd/itd (KF09)
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912550
|
mll-af9 + kras g12d/+ (KF09)
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912551
|
Pool 1 - MLL-AF9 KRAS M8 & MLL M2
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912552
|
Pool 2 - FLT3 M11 & COMBO 1-1-1 M17
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912553
|
Pool 3 - MLL M3 & FLT3 M12
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912554
|
Pool 4 - COMBO 1-1-1 M19 & COMBO 80-15-5 M22
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM4912555
|
Pool 5 - KRAS M10 & COMBO 80-15-5 M24
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM5643580
|
chemo baseline scRNAseq tech rep 1
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM5643581
|
chemo baseline scRNAseq tech rep 2
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM5643582
|
chemo disease endpoint scRNA-seq pool 1
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM5643583
|
chemo disease endpoint scRNA-seq pool 2
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|
GSM5643584
|
chemo disease endpoint scRNA-seq pool 1 hashtag library
|
SRA
|
|
1 |
|
|
|
Mark Dawson
|
Nov 08, 2021
|